To identify genes whose expression is upregulated in lung adenocarcinoma (AdC) cells in comparison with noncancerous peripheral lung epithelial cells, type II alveolar cells and bronchiolar epithelial cells, as well as AdC cells, were isolated by laser capture microdissection, and subjected to cDNA microarray analysis of 637 human cancer-related genes. Each of the component cells was obtained from several different individuals and analysed independently. As a comparison, two lung AdC cell lines and two primarily cultured normal lung epithelial cell lines were also subjected to cDNA microarray analysis. Four genes, TOP2A, MMP15, MX2 and KOC1, were commonly upregulated in microdissected AdC cells in comparison with microdissected epithelial cells. Hierarchical clustering analysis revealed that differences in geneexpression profiles were more evident between cultured and uncultured cells than between cancerous and noncancerous cells. To further identify the common molecular targets of AdC cells in vivo, quantitative real-time RT-PCR was performed against the four genes upregulated by cDNA microarray analysis. The TOP2A, MMP15, MX2 and KOC1 genes were overexpressed in 10/10 (100%), 8/10 (80%), 5/10 (50%) and 3/10 (30%) microdissected AdC cell samples, respectively, in comparison with any of nine independently microdissected noncancerous epithelial cell samples. The TOP2A gene was commonly overexpressed in lung AdC cells, as previously reported. In addition, the MMP15 and MX2 genes were identified, for the first time, as being commonly overexpressed in lung AdC cells. These results strongly indicate that the MMP15 and MX2 genes could be novel markers for molecular diagnosis and therapy of lung AdC.
Introduction
Lung cancer is the leading cause of cancer-related death in the world. In particular, the incidence of lung adenocarcinoma (AdC) is still rising in many countries (Yoshimi et al., 2003) . The high mortality of this disease is largely attributable to difficulties in early diagnosis and lack of effective therapeutic methods. To contribute to the improvement of survival rates in lung AdC patients, better tumor markers for diagnosis and new molecular targets for drug development are needed. Recent studies have suggested that information on geneexpression profiles of cancer cells obtained by cDNA microarray analyses can be used to develop a molecular diagnosis of human cancers (Sugita et al., 2002) and to identify the molecular targets in cancer cells for treatment (Wang et al., 2000 (Wang et al., , 2001 (Wang et al., , 2003 . In fact, a variety of genes have been identified by cDNA microarray analysis as being differentially expressed between lung AdC cells and noncancerous lung cells (Bhattacharjee et al., 2001; Garber et al., 2001) . However, there have been considerable differences in identified genes among the reports.
The purpose of this study is, by cDNA microarray analysis, to identify genes whose expression is upregulated in lung AdC cells in comparison with noncancerous lung epithelial cells, which can be used as diagnostic markers and/or drug targets for lung AdC. In lung cancer, cDNA microarray analyses have been performed mostly by using macrodissected samples and cultured cancer cell lines as cancer cells, and by using macrodissected samples or primarily cultured lung epithelial cells as noncancerous cells (Bhattacharjee et al., 2001; Garber et al., 2001; Goodwin et al., 2001; Wang et al., 2001; Beer et al., 2002; McDoniels-Silvers et al., 2002; Miura et al., 2002; Sugita et al., 2002; Wikman et al., 2002) . However, macrodissected lung tissue samples consist of a mixture of cells, including type I and II alveolar epithelial cells, bronchial and bronchiolar epithelial cells, endothelial cells, fibroblasts and macrophages, and the proportion of each cell type varies among anatomical regions. Thus, differences in the results of cDNA microarray analyses could be largely due to the differences in cell populations prepared for each study. Therefore, the analysis of macrodissected cells would be less effective than that of microdissected cells to identify genes specifically expressed in individual cell types. Cultured normal lung epithelial cells, such as normal lung small airway epithelial cells (SAEC) and normal bronchial/tracheal epithelial cells (NHBE), have been often used as representatives of normal lung epithelial cells. However, gene-expression profiles of NHBE as well as SAEC cultured in vitro could be different from those of lung epithelial cells in vivo, since a recent cDNA microarray analysis of primary lung tumors and lung cancer cell lines identified a large group of genes differentially expressed between uncultured and cultured cancer cells (Virtanen et al., 2002) . Therefore, analysis of cultured cells could also be inappropriate to identify genes specifically expressed in vivo in individual cell types.
The majority of lung AdC develop in the regions of peripheral bronchioles and alveoli. The cellular origins of peripheral AdC are thought to be bronchiolar and alveolar epithelial cells, especially Clara cells and type II alveolar cells, respectively. Therefore, to obtain more critical information about the gene-expression profiles unique to lung AdC cells, it is preferable to compare the profiles between pure populations of cancer cells and those of bronchiolar and alveolar epithelial cells. For this reason, in this study, to better understand geneexpression profiles of lung AdC cells as well as normal lung epithelial cells in vivo, the profiles were generated from lung AdC cells, type II alveolar cells and bronchiolar epithelial cells, all of which were obtained by laser capture microdissection (LCM) as pure populations. Those profiles were then compared to identify genes that are differentially expressed in cancerous and noncancerous lung cells in vivo. Here, we describe the identification of novel genes whose expression is upregulated in lung AdC cells by combining LCM and cDNA microarray techniques.
Results

Laser capture microdissection of lung adenocarcinoma cells, type II alveolar cells and bronchiolar epithelial cells
Two cases of AdC samples, type II alveolar epithelial cell samples and bronchiolar epithelial cell samples, respectively, were first prepared by the LCM method (Figure 1) . Histologically, one of the AdC was classified as being poorly differentiated (T1), and the other was classified as being well-differentiated (T2). Type II alveolar epithelial cells were also obtained from these two cases, while bronchiolar epithelial cells were from different cases. Microscopic visualizations of representative tissue sections are shown in Figure 1A . Most of the alveolar surface is lined by type I alveolar epithelial cells with a flattened shape, while type II alveolar epithelial cells with a more cuboidal or domed shape are scattered in the alveolar surface. Thus, every single type II alveolar cell was independently microdissected (Figure 1Aa ). The respiratory bronchioles, lined by a single cell layer, consist of ciliated and nonciliated columnar cells. Nonciliated columnar cells are called Clara cells. Both Clara cells and ciliated bronchiolar epithelial cells were microdissected together ( Figure  1Ab) . As much as possible, a pure population of AdC cells were microdissected by the same method ( Figure  1Ac ). Approximately 2000 cells were microdissected from each sample.
Total RNA was extracted from the target cells, and the quality, quantity and purity of RNAs were assessed by RT-PCR analysis of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), surfactant pulmonary-associated protein A (SPA), surfactant pulmonary-associated protein B (SPB) and a Clara-cell-specific 10-kDa protein (CC10). SPA mRNA is known to be expressed in type II alveolar cells but not in bronchiolar epithelial cells, whereas SPB mRNA is expressed in both type II alveolar cells and bronchiolar epithelial cells (Phelps and Floros, 1988) . CC10 mRNA is known to be expressed in Clara cells in the bronchiolar epithelium, but not in type II alveolar cells (Jensen et al., 1994) . As shown in Figure 1B , RNA was of sufficient quality and quantity to be reverse transcribed and amplified using specific primers for GAPDH. Thus, the quality of RNA from type II alveolar cells and bronchiolar epithelial cells, as well as AdC cells, was well preserved after LCM, and RNA amounts of individual cell types were sufficient for cDNA microarray analysis. As expected, SPA specific signals were detected only in lanes for RNA isolated from type II alveolar cells and not for RNA isolated from bronchiolar epithelial cells. In contrast, CC10 specific products were not amplified from RNA isolated from type II alveolar cells, but were amplified from RNA from bronchiolar epithelial cells. SPB specific bands were detected in both type II alveolar cells and bronchiolar epithelial cells. The results indicated that the proportions of type II alveolar cells as well as bronchiolar epithelial cells were considerably enriched by LCM.
cDNA microarray analysis of lung adenocarcinoma cells and noncancerous lung epithelial cells RNA from two each of AdC, type II alveolar epithelial cell and bronchiolar epithelial cell samples described above was reverse transcribed and subjected to T7-based RNA amplification, using the TALPAT (T7 RNA polymerase-mediated transcription, adaptor ligation, PCR amplification followed by T7-transcription) method (Aoyagi et al., 2003) , to increase the amount of RNA. Total RNAs prepared from primarily cultured lung epithelial cells, NHBE and SAEC, and from lung AdC cell lines, PC14 and A549, were also reverse transcribed and subjected to TALPAT amplification. Experimental and reference probes were mixed and hybridized together to a cDNA microarray containing 637 cancer-related genes. A probe for NHBE cells was used as a reference in each experiment. If a gene was judged as being expressed in NHBE cells, we calculated the level of gene expression in an experimental sample relative to that in NHBE cells. If a gene was judged as being not expressed in NHBE cells, we judged whether it was expressed or not expressed in each experiment sample.
Hierarchical clustering was performed among 10 samples analysed with 308 genes that were judged as being expressed in NHBE cells. Figure 1C shows relationships among them by two-dimensional clustering of gene-expression profiles. As expected, each of two samples derived from the same cell types was clustered into the same terminal branch, except for SAEC and NHBE. The most notable finding of clustering analysis was that the 10 samples were first divided into two groups of cultured cells and uncultured cells. The group of uncultured cells was further divided into cancerous cells and noncancerous cells. Finally, two of the type II alveolar cell samples and two of the microdissected bronchiolar epithelial cell samples were divided into different branches. These results strongly indicated that differences in gene-expression profiles were more evident between cultured and uncultured cells than between cancerous and noncancerous cells, and that comparative studies for gene-expression profiles using either cancer cell lines or primarily cultured lung epithelial cells could over-or underestimate the differences in the profiles between AdC cells and bronchiolar and alveolar epithelial cells in vivo. Therefore, further comparative In addition to the two each of AdC, type II alveolar epithelial cell and bronchiolar epithelial cell samples described above, three cases of AdC cells, one case of type II alveolar cells and one case of bronchiolar epithelial cells, all of which were obtained from different patients, were subjected to cDNA microarray analysis. Thus, expression profiles of 637 genes for 11 samples in total were obtained. Then, genes whose expression is upregulated in lung AdC cells were searched for from the 637 genes. From 308 genes that were judged as being expressed in NHBE cells, we selected genes that were commonly overexpressed (more than three-fold differences in signal intensities) in microdissected AdC cells in comparison with type II alveolar and bronchiolar epithelial cells (Table 1) . From the remaining 329 genes that were judged as being not expressed in NHBE cells, we selected genes that were commonly detectable in microdissected AdC cells and not detectable in type II alveolar cells and bronchiolar epithelial cells. Two genes, IGF-II mRNA-binding protein 3 (KOC1) and topoisomerase (DNA) II alpha (170 kD) (TOP2A), were identified as being upregulated commonly in AdC cells in vivo. Another two genes, matrix metalloproteinase 15 (MMP15) and myxovirus (influenza virus) resistance 2 (MX2), were detectable only and commonly in AdC cells and not in noncancerous epithelial cells in vivo.
As a comparison, fluorescence values of the four genes, whose overexpression was observed in AdC cells in vivo, in cultured normal lung epithelial cells, NHBE and SAEC, and lung cancer cell lines, PC-14 and A549, were also listed in Table 1 . Two genes, KOC1 and TOP2A, were also overexpressed in both of the two AdC cell lines. The MMP15 gene, which was detectable in primary AdC cells, was not detectable in either AdC cell line, whereas the MX2 gene was detectable in only one of the two AdC cell lines. Thus, as expected from the clustering analysis, gene-expression profiles were considerably different between cultured and uncultured cells of both cancerous and noncancerous origins.
Quantitative real-time RT-PCR analysis of genes judged as being upregulated in adenocarcinoma cells by cDNA microarray analysis Expression levels of four genes judged as being upregulated by cDNA microarray analysis were verified by quantitative real-time RT-PCR (QRT-PCR) using cDNAs of 19 microdissected samples. The 19 samples consisted of 11 samples used for the microarray analysis and an additional two cases of type II alveolar cells, one case of bronchiolar epithelial cells, and five cases of lung AdC cells, which were obtained from different patients. To comparatively assess the amount of mRNA for these genes, the ATP synthase (ATP5F1) gene was used as an internal control, since this gene showed less variable and more moderate expression levels than seven other housekeeping genes among the 10 samples in the cDNA microarray analysis. The mRNA levels of the TOP2A, MMP15, MX2 and KOC1 genes were more than two times higher in 10/10 (100%), 8/10 (80%), 5/10 (50%) and 3/10 (30%) AdC samples than those in all the nine microdissected noncancerous lung epithelial cell samples (Figure 2 ). In particular, TOP2A mRNAs were under the level of detection in any of the nine noncancerous cell samples but detected in all the 10 AdC cell samples, and the levels of MMP15 mRNA in two cases of AdC cells were more than 10 times higher than those in any cases of noncancerous cell samples (cases 14 and 17 in Figure 2c ). Thus, the results of QRT-PCR were consistent with the expression levels generated by cDNA microarray data, and the QRT-PCR analysis revealed that the TOP2A and MMP15 genes are overexpressed in the majority of lung AdC and the KOC1 and MX2 genes are overexpressed in a subset of lung AdC.
Discussion
A novel aspect of this study is the application of cDNA microarray analysis on microdissected cancerous and noncancerous lung cells to reveal component cellspecific gene-expression profiles and to identify the possible molecular markers/targets for lung AdC. This approach revealed, for the first time, the gene-expression We identified four genes that were overexpressed commonly in lung AdC cells. A good indication for the success of this approach is the fact that two genes known to be highly expressed in lung cancer cells, TOP2A and KOC1, were also identified in this study (Giaccone et al., 1995; Syahruddin et al., 1998; Wang et al., 2003) . Furthermore, the MMP15 and MX2 genes were identified for the first time as being commonly overexpressed in lung AdC cells in vivo. Thus, our data on microdissected AdC cells and noncancerous bronchiolar and alveolar epithelial cells confirmed and extended the findings of recent microarray studies. Overexpression of the four genes selected by cDNA microarray analysis was confirmed by quantitative RT-PCR against 19 samples, including an additional five AdC and three lung epithelial cell samples. However, the number of samples analysed for these genes is still small; therefore, the prevalence and specificity of their overexpression in AdC cells should be further examined in a larger number of samples to define their utility as novel molecular markers for diagnosis and therapy of lung AdC. Matrix metalloproteinases (MMPs) are a family of zinc-and calcium-dependent enzymes involved in the degradation of numerous extracellular matrix (ECM) components (Polette and Birembaut, 1998) . The MMP15 gene, also called MT2-MMP, encodes a membrane-type MMP (MT-MMP). Another MT-MMP, MMP14, also called MT1-MMP, has been reported to play a major role in the activation of gelatinase A (MMP2), and is known to be overexpressed in various types of human cancers, including lung cancer (Sato et al., 1994; Tokuraku et al., 1995; Pollete et al., 1996; Nawrocki et al., 1997) . MMP15 has been also reported as being overexpressed in urothelial carcinoma, breast carcinoma and astrocytic tumors (Ueno et al., 1997; Kitagawa et al., 1998; Nakada et al., 1999) . In one of those studies, it was suggested that both MMP14 and MMP15 play a key role in the activation of MMP2 in malignant astrocytic tumors and that the gelatinolytic activity is involved in astrocytic tumor invasion (Nakada et al., 1999) . cDNA for other MMPs, MMP1, MMP2, MMP3, MMP7, MMP9, MMP12, MMP13, MMP15 and MMP19, were on the microarray used in this study; however, no MMPs other than MMP15 were judged as being highly expressed in lung AdC cells. Thus, MMP15 expression might be associated with the Gene-expression profile of lung adenocarcinoma K Kobayashi et al invasive phenotype of lung AdC cells, and could be a useful biomarker for lung AdC. The MX2 gene, also called MxB, belongs to the family of large GTPases. Previously, it was reported that MxB protein was poorly expressed in A549 cells, with expression being increased by IFN-a treatment (Melen et al., 1996) . In prostate cancer cell lines, MxB was upregulated in androgen-independent cell lines, but not expressed in androgen-dependent cell lines (Vaarala et al., 2000) . Thus, MX2 expression might also be a useful biomarker for lung AdC.
The TOP2A gene encodes a protein of topoisomerase II a, which is an essential nuclear enzyme for chromosome segregation during mitosis (Watt and Hickson, 1994) . Previous studies on lung carcinoma revealed that TOP2A gene expression in cancer cells was significantly higher than that in noncancerous lung cells in vivo (Giaccone et al., 1995; Syahruddin et al., 1998) . More recently, Mirski et al. (2000) reported a histologic typerelated difference in the level of TOP2A mRNA expression. The increase in its expression was less evident in squamous cell carcinoma than in AdC. The present result was consistent with those studies, and further indicate that TOP2A is not expressed in noncancerous bronchiolar and alveolar epithelial cells, while it is highly expressed in most of, if not in all of, lung AdC cases in vivo. The KOC1 gene encodes KOC protein, which contains an RNA-binding motif known as the KH domain. It was first isolated as a gene overexpressed in human pancreatic cancer (Mueller-Pillasch et al., 1997) , and is thought to play a role in tumor cell proliferation. Recently, the KOC gene was also identified by a cDNA microarray analysis as being moderately overexpressed in lung squamous cell carcinoma (Wang et al., 2000) . This study also revealed that the KOC1 gene is overexpressed in approximately 30% of lung AdC cases. These results indicate that the KOC gene is overexpressed in a subset of both AdC and squamous cell carcinomas of the lung.
LCM and subsequent cDNA microarray analyses allowed us to identify several novel genes, which are differentially expressed between AdC cells and noncancerous bronchiolar and alveolar epithelial cells. In this study, type II alveolar cells and bronchiolar epithelial cells showed a significant difference in geneexpression profiles. Thus, it will be of great importance to compare the profiles among various types of bronchiolar and alveolar epithelial cells to understand the processes of growth and differentiation of normal lung epithelial cells. Lung AdC is classified into several histological subtypes; thus, it would also be important to compare the profiles among those subtypes for the development of molecular classification of lung AdC. Finally, it should be noted that cDNA microarray analysis including a broader range of genes would also be necessary, since only 637 genes were screened for differential expression in this study. For these reasons, we are now conducting an expressionprofiling study against more than 10 000 genes, with a larger number of and with several different sets of materials.
Materials and methods
Samples
Two pairs of primary lung AdCs and normal lung tissues, eight primary lung AdCs and six normal lung tissues were obtained at surgery at the National Cancer Center Hospital, Tokyo, Japan. Histological typing of the tumors was based on the World Health Organization classification (Travis et al., 1999) . Disease stage was determined according to the TNM classification of the International Union Against Cancer (Sobin and Wittekind, 2002) . Stages and subtypes of 10 AdCs are as follows. PD, MD and WD stand for poorly differentiated, moderately differentiated and well-differentiated, respectively. T1 IIIA/PD; T2 IIIA/WD; T3 IB/WD; T4 IA/WD; T5 IIB/WD; T6 IIIA/MD; T7 IIB/MD; T8 IB/ MD; T9 IB/PD; T10 IIB/PD. Normal lung tissues were gently expanded in a 10 ml syringe containing 25% (V/V) TissueTek OCT (Sakura, Tokyo, Japan)/PBS medium, and were subsequently embedded in the OCT medium. Tumor tissues were embedded in the OCT medium without expansion. Primary cultured lung epithelial cells, SAEC and NHBE were purchased from Clonetics/BioWhittaker (San Diego, CA, USA), and were propagated within four passages according to the manufacturer's instructions. Lung AdC cell lines, A549 and PC14, were cultured with the RPMI1640 medium (Nissui Pharmaceutical, Tokyo, Japan) containing 10% fetal bovine serum. The OCT-embedded tissues and the cultured cells harvested by trypsinization were kept frozen at À801C.
Laser capture microdissection and total RNA extraction OCT-embedded tissues were sectioned at 8 mm in thickness using a cryostat, mounted on noncoated glass slides, and stored at À801C. The sections were stained with hematoxylin (1 min) and eosin (5 s); and were dehydrated by a series of 70% ethanol (1 min), 100% ethanol (1 min) and xylene (3 min) treatments. Once air-dried, desired cells were microdissected onto CapSuret transfer films (Arcturus Engineering, Mountain View, CA, USA) using the PixCell II LCM System (Acturus Engineering, Mountain View, CA, USA) under the following conditions: laser diameter 7.5 mm; pulse duration 1.0 ms; and amplitude 90 mW. To avoid contamination of undesired cells due to direct attachment of the specimen to the film, pieces of membrane of 8-10 mm thickness (VMTP04700, Millipore) were put as a spacer between the film and the specimen. In all, 2000 type II alveolar, bronchiolar epithelial and AdC cells were captured, and total RNA was extracted from the microdissected cells using a Micro RNA Isolation Kit (Stratagene, San Diego, CA, USA), as described previously (Emmert-Buck et al., 1996; Crnogorac-Jurcevic et al., 2002) . Total RNA was also prepared from cultured cells using the RNeasy kit (Qiagen, Valencia, CA, USA).
RT-PCR analysis
All the RNA samples obtained from microdissected cells were subjected to a quality examination. Briefly, RNA from approximately 1000 cells was reverse transcribed on a scale of 20 ml, using Sensiscriptt transcriptase (Qiagen, Valencia, CA, USA) with oligo(dT) 24 primer, according to the supplier's protocol. A volume of 1 ml of the cDNA solution was then subjected to PCR amplification of cDNA fragments for the GAPDH, SPA, SPB and CC10 genes, using HotStarTaq DNA polymerase (Qiagen, Valencia, CA, USA) 0 -CCACCATGAAACTCGGTGTC-3 0 , and 5 0 -GTGGGCGTGGACTCAAAGC-3 0 for the CC10 gene. PCR products were electrophoresed on 1.5% agarose gel and stained with ethidium bromide.
cDNA microarray hybridization
RNA from approximately 1000 type II alveolar, bronchiolar epithelial and AdC cells, respectively, and 50 ng of RNAs from cultured cells were subjected to PCR-mediated global mRNA amplification using the TALPAT method (Aoyagi et al., 2003) . Briefly, first-strand cDNA was synthesized from RNA by Sensiscriptt reverse transcriptase (Qiagen, Valencia, CA, USA) with oligo(dT) 24 -T7 primer, and subsequently, secondstrand cDNA was synthesized by DNA polymerase I and RNase H. After end-filling by T4 DNA polymerase, ds-cDNA synthesized was subjected to a single round of cDNA amplification consisting of a cRNA amplification by in vitro transcription using T7 RNA polymerase and a subsequent cDNA synthesis with random hexamer primer for the firststrand cDNA and oligo(dT)-T7 promoter primer for the second-strand cDNA. After end-filling by T4 DNA polymerase, ds-cDNA was further amplified by 30 cycles of adaptorligation PCR. A measure of 1 mg of amplified cDNA was again converted to cRNA by in vitro transcription using T7 RNA polymerase, and 5 mg of cRNA synthesized was labeled with Cy5-deoxyuridene triphosphate (dUTP) or Cy3-dUTP (Amersham Pharmacia Biotech, UK) by reverse transcription using reverse transcriptase XL (Takara). cRNA from NHBE cells was used as a common reference. We examined pairs of arrays in which the experimental sample was labeled with Cy5 and the reference with Cy3 for one array, and the labelling was reversed in the other array. Cy5-labeled and Cy3-labeled cDNA probes were mixed, and were hybridized to IntelliGene Human Cancer CHIP version 3.0, according to the supplier's protocol. This cDNA array contained 637 genes, whose implication in carcinogenesis was indicated by previous studies including differential display analyses between cancerous and noncancerous cells, eight housekeeping genes and five external control genes (Takara Shuzo Co. Ltd, Tokyo, Japan; information available at http://www.takara-bio.co.jp/english/ index.htm). The slides were scanned with a GMS418 Array Scanner (Genetic Microsystems, Woburn, MA, USA).
Data analysis
The intensity of each hybridization signal was evaluated using a computer program, ImaGene version 3.0. (BioDiscovery, Los Angeles, CA, USA). The local background was subtracted for all spots and global normalization was performed in each slide. Genes for which the intensities of spots were less than the average intensities for six negative non-human control genes plus 3 s.d. were judged as being not expressed. The level of gene expression was expressed by the ratio of experimental/ reference intensity, and the average of the ratios from duplicate profiles was imported to CLUSTER software (http://rana.stanford.edu/software/) and the output was visualized as a dendrogram by TREEVIEW (http://rana.stanford.edu/software/) software (Eisen et al., 1998) .
QRT-PCR analysis
Expression levels of the MMP15, KOC1, TOP2A and MX2 genes were measured by QRT-PCR using a Quantitectt Probe PCR kit (Qiagen, Valencia, CA, USA) and the ABI Prism 7900 HT sequence detection system (Applied Biosystems, CA, USA). cDNAs produced by reverse transcription using Sensiscriptt transcriptase (Qiagen, Valencia, CA, USA) with oligo(dT) 24 primer as described in RT-PCR analysis were used as templates. The expression level of each gene was normalized to RNA content for each sample by using ATP5F1 as an internal control. A primer pair and a TaqMan probe for each gene were designed by using Primer Express software based on the published sequences as follows: MMP15, 5 0 -GGGGA GATGTTCGTGTTCAAG-3 0 (sense), 5 0 -GCATGGGATAG TTGTCCAGGA-3 0 (antisense), and 5 0 -TTCTGGCGAGTCC GGCACAACC-3 0 (FAM-labelled probe); KOC1, 5 0 -CGT GACCAGACACCTGATGAGA-3 0 (sense), 5 0 -CTGTTGTT GGTGCTGCTTTACC-3 0 (antisense), 5 0 -CACTTCTATGC TTGCCAGGTTGCCCA-3 0 (FAM-labelled probe); TOP2A, 
